{"result_id": "086010", "URL": "https://www.cureus.com/articles/100523-an-unusual-side-effect-of-the-covid-19-vaccine-a-possible-trigger-of-polymyalgia-rheumatica", "timestamp": "2023-04-25 14:53:03 CEST+0200", "meta": {"description": "Polymyalgia rheumatica (PMR) is characterized by myalgia and severe stiffness with decreased range of motion in the shoulder and pelvic girdles. The efficacy of the BNT 162b2 Pfizer vaccine has been proven and has been well-tolerated by patients; however, some instances of PMR have been reported after the COVID-19 vaccine. We are writing a case of a new-onset PMR in a 72-year-old woman with typical findings after receiving a booster dose of the BNT 162b2 Pfizer vaccine. This case report highlights that PMR should be in the differential diagnosis of myalgias caused by the vaccine.", "lang": "en", "keywords": "", "favicon": "https://assets.cureus.com/packs/media/images/favicon-6b3259c58f4356da2cc885357cfda20b.png", "canonical": "https://www.cureus.com/articles/100523-an-unusual-side-effect-of-the-covid-19-vaccine-a-possible-trigger-of-polymyalgia-rheumatica", "encoding": "utf-8"}, "image": null, "domain": "www.cureus.com", "title": "An Unusual Side Effect of the COVID-19 Vaccine: A Possible Trigger of Polymyalgia Rheumatica", "cleaned_text": "On May 25, 2018, the GDPR (General Data Protection Regulation) went into effect and changed how organizations deal with personal data of customers located in the EU. Though GDPR was built to protect Europeans, it will affect organizations around the world doing business in the EU. Because of this we are asking our users located in the EU to opt in to the data we collect in order to bring a better web experience. Opt-In", "opengraph": {"title": "An Unusual Side Effect of the COVID-19 Vaccine: A Possible Trigger of Polymyalgia Rheumatica", "type": "article", "image": "https://public.cureus.com/fallback/new_default_article_image_3.png", "description": "Polymyalgia rheumatica (PMR) is characterized by myalgia and severe stiffness with decreased range of motion in the shoulder and pelvic girdles. The efficacy of the BNT 162b2 Pfizer vaccine has been proven and has been well-tolerated by patients; however, some instances of PMR have been reported after the COVID-19 vaccine. We are writing a case of a new-onset PMR in a 72-year-old woman with typical findings after receiving a booster dose of the BNT 162b2 Pfizer vaccine. This case report highlights that PMR should be in the differential diagnosis of myalgias caused by the vaccine.\u00a0"}, "tags": [], "tweets": [], "movies": [], "links": ["/users/gdpr_opt_in"], "authors": ["Anam Ahmad", "Donica L. Baker"], "publish_date": null}